Nurix Therapeutics, Inc.
Nurix Therapeutics develops small-molecule medicines that harness the ubiquitin–proteasome system to degrade disease-causing proteins, targeting cancers and immune disorders. The company advances an internal clinical pipeline and partnered programs, generating revenue through collaborations alongside eventual drug commercialization. Founded in 2012 and headquartered in Brisbane, California, Nurix is a publicly traded company on NASDAQ.
Open Positions at Nurix Therapeutics, Inc.
2 open positions
Build and deploy custom AI and LLM-powered applications for clients, combining backend engineering, cloud deployment, and machine learning. The role offers the opportunity to deliver innovative AI solutions in a collaborative, fast-growing team.
Build production-grade speech and conversational AI systems for multilingual Indian contexts, including custom ASR/TTS models, voice-to-voice agents, and agentic RAG pipelines. This onsite Bangalore role focuses on low-latency, real-time ML at scale.